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1. Introduction
1.1. Epidemiology
Microbial keratitis is a potentially serious corneal infection and a major cause of visual im‐
pairment worldwide.  A conservative estimate of  the number of  corneal  ulcers occurring
annually in the developing world alone is 1.5–2 million [1].  The incidence of this condi‐
tion varies from 11.0 per 100 000 person years in the United States to 799 per 100 000 per‐
son years  the  developing nation of  Nepal  [2,  3].  Microbial  keratitis  is  thus  a  significant
public health problem, and numerous studies have been performed describing the micro‐
biology of corneal infection. Wide geographical variation exists in the epidemiology of mi‐
crobial keratitis based on economic and climate factors. To some degree, this variation is
explained by economic factors as well as contact-lens wear. A high proportion of bacterial
ulcers were reported from centres in developed countries (North America, Australia and
Western Europe). In these countries, patients are far less likely to be agricultural workers,
and so have a reduced risk of trauma from organic matter, which is known to be a risk
factor for fungal infection.
Almost any microorganism can invade the corneal stroma if the normal corneal defense
mechanisms are compromised. A wide spectrum of microbial organisms can produce cor‐
neal infections and, consequently, the therapeutic strategies adopted for its treatment may
be varied. As there is no definite pathognomonic clinical feature, it is difficult to establish
the aetiology of corneal ulcer merely on the basis of clinical features. Hence, microbiological
evaluation is a must in order to attain a definitive diagnosis and to ensure specific therapy
for keratitis.
© 2013 Robles-Contreras et al.; licensee InTech. This is an open access article distributed under the terms of
the Creative Commons Attribution License (http://creativecommons.org/licenses/by/3.0), which permits
unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
Regarding bacterial keratitis there are several potential risk factors such as contact lenses,
trauma, aqueous tear deficiencies, neurotrophic keratopathy, eyelid alterations or malposi‐
tion, decreased immunologic defenses, use of topical corticoid medications and surgery [4].
Trauma is a major risk factor for corneal infection in developing countries. In Paraguay, the
percentage of cases with preceding trauma was 48%, in Madurai, South India, 65% and 83%
in Eastern India [5, 6, 7]. By far the most common cause of trauma to the corneal epithelium
and the main risk factor for bacterial keratitis in developed countries is the use of contact
lenses, particularly extended-wear contact lenses. Patients with bacterial keratitis, 19-42%
are contact lens wearers; incidence of bacterial keratitis secondary to use of extended-wear
contact lenses is about 8,000 cases per year. The annual incidence of bacterial keratitis with
daily-wear lenses is 3 cases per 10,000 [8].
Traditionally the more common groups responsible for bacterial keratitis are: Streptococcus sp.,
Pseudomonas sp., Enterobacteriaceae (including Klebsiella, Enterobacter, Serratia, and Proteus), and
Staphylococcus sp. Although there is also a wide variation depending on the setting of the series
reported. A high percentage of Staphylococcus sp. (79%) was recorded in a study from Para‐
guay, although the reason for this is not clear. Another study found the highest proportion of
Streptococcus sp. (46.8%), the authors noted that this figure was only 18.5% in 1986 and suggest
that the trend might represent a genuine change in the bacterial flora owing to changes in the
climate and environment [9]. A study from Bangkok [10] had the highest proportion of Pseudo‐
monas infections (55%). Interestingly, this study did not have the highest proportion of con‐
tact-lens wearers. Other studies reported far higher proportions of contact-lens wearers—for
example, 44% in a study from Taiwan [11] and 50% in a study from Paris [12]. When compared
the percentage of contact-lens wearers with the percentage of pseudomonal infections, the
Spearman correlation coefficient was not statistically significant. Cohen et al. at Wills Eye Hos‐
pital reported a decline in contact lens-related ulcers: during 1991 to 1998, contact-lens wear
accounted for 44% of all ulcers, but during 1992 to 1995, it accounted for only 30%. Liesegang
reports the following risk factors for development of bacterial keratitis among contact lenses
wearers: overnight wear, smoking, male sex, and socioeconomic status. The risk with thera‐
peutic contact lenses is much higher: approximately 52/10,000 per year [13].
Jeng [14] commented on the emerging resistance of bacterial infections to fluoroquinolones.
In addition to changes in resistance patterns, studies have also demonstrated changing pat‐
terns of causative organisms over time in a given geographical location. Varaprasathan et al
[15] reported that the proportion of Streptococcus pneumoniae and Pesudomonas aeruginosa ul‐
cers in Northern California had decreased over a 50-year period, while that of Serratia mar‐
cescens had increased over the same period. Sun et al [16] reported a rise in the percentage of
Gram positive (+) cocci in North China from 25% in 1991 to 70.8% in 1997, as well as a de‐
crease in Gram negative (-) bacilli from 69% to 23.4% over a similar period. Hsiao et al [17]
reported on a 10 year follow up that there was a significant decrease in the percentage of
Gram(+) microorganisms over time. The sensitivity of Gram(-) isolates to tested antimicrobi‐
als was >97% response for all the reported antibiotics; this was not the case for Gram(+) iso‐
lates, in which resistance to the antibiotics was more common, methicillin-resistant
organisms accounted for 29.1% of all Gram(+) cultures.
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The overview of bacterial keratitis is quite extensive, from the epidemiological point of view
is important to consider the wide variety of presentations even within the same regions of a
country. Microbiological studies are essential to determine the casuistry of each center in a
given time. A common problem throughout the world is the ever increasing resistance to an‐
tibiotics including the new fluoroquinolones.
2. Immune response
We have a lot of mechanisms to evade a bacterial infection: physical, chemical, microbiologi‐
cal, and immunological mechanisms. But not all of the mechanisms are described in a bacte‐
rial keratitis infection.
2.1. Exterior defense
The eye has several mechanisms to prevent colonization by bacteria, among which are three
main types: the mechanics, such as blinking, or that the Tight Junctions present in the cor‐
neal epithelial cells, preventing the entry of bacteria into the corneal stroma or other intraoc‐
ular structures, it is important to mention that certain bacteria are able to penetrate the intact
corneal epithelium such as Corynebacterium diphtheriae, Haemophilus aegyptus, Neisseria sp.,
Listeria sp. and Shigella sp. [18, 19]; Chemicals, which are the presence of soluble molecules
involved in controlling the growth of bacteria, such mechanisms are presence of lactoferrin,
lysozyme, antimicrobial peptides, antibodies, etc. [20-21] and finally microbiologic mecha‐
nisms, these mechanisms refer the normal microbiota of the ocular surface (S. epidermidis, S.
aureus and Propionibacterium sp.) [22-26], the microbiota generates substances called bacterio‐
cins, which will be mentioned later in item 3 of this chapter.
2.2. Complement
It was reported in murine models, that anaphylatoxins (C3a, C4a, and C5a) could be gener‐
ated when the cornea was injured with lipopolysaccharides (LPS), immune complexes, acid,
or alkali. Interestingly membrane attack complex (MAC) could only be generated when the
cornea was exposed to LPS or immune complexes. Cornea failed to generate MAC when af‐
fronted with acid or alkali. The immune response mounted to LPS or immune complex is
similar to that generated against infectious agents like Gram(-) bacteria. Indeed the comple‐
ment system has been shown to play a critical role in protection against Pseudomonas aerugi‐
nosa infection that causes keratitis [27,28]. Additionally, complement activation is believed
to play an important role in ulceration of human cornea induced by Gram(-) bacteria [29].
2.3. Receptors
There are different receptors that recognizes bacteria molecules, these receptors in general
are called pattern recognition receptors and exists several types of receptors (TLR, CLR,
NLR and RLR). In bacterial keratitis infections are studied in murine and in vitro models, the
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presence, activation and function of TLR. The functions described in TLR activation are cy‐
tokine secretion, chemokines secretion, and antimicrobian peptides secretion, recruitment of
cells to inflammation site. For example corneal TLR4 expression is increased in P. aeruginosa
infection and deficiency of this receptor in BALB/c mice resulted in a susceptible rather than
resistant phenotype [30], these observations suggest that TLR4 is critical for resistance to P.
aeruginosa keratitis.
2.4. Effects of receptors activation
2.4.1. Chemokines
In other studies, UV killed S. aureus and Pam3Cys (TLR2 synthetic ligand) stimulated the
phosphorylation of MAP kinases, JNK, p38 MAPK and ERK, and the blockade of JNK, but
not that of p38 or ERK phosphorylation, had an inhibitory effect on IκBα degradation and
CXC chemokine production [31]. Furthermore they also found that corneal inflammation
was significantly impaired in mice deficient in JNK1 mice compared with control mice, sug‐
gesting that JNK has an essential role in TLR2-induced corneal inflammation.
2.4.2. Antimicrobian peptides
Activation with pathogens and TLR agonists of ocular surface epithelial cells by also leads
to the production of antimicrobial peptides such as hBD-2 and the cathelicidin LL-37 [32-34].
In an interesting in vitro study [35], Maltseva et al., reported that a MyD88 dependent in‐
crease in corneal epithelial hBD-2 expression caused by exposure to P. aeruginosa superna‐
tant was abrogated by the presence of a contact lens, thus giving new insight into the
mechanism by which contact lens wear predisposes to P. aeruginosa keratitis.
Additional in vivo studies have shown that defensins and LL-37 play an important role in
protecting the ocular surface from P. aeruginosa infections. In particular, mice deficient in
cathelicidin-related antimicrobial peptide (CRAMP), the murine homologue of LL-37, are
more susceptible to P. aeruginosa keratitis, had significantly delayed bacterial clearance and
an increased number of infiltrating neutrophils in the cornea [36]. A similar finding was re‐
ported in BALB/c mice following knock down of mBD-2 or mBD-3, but not of mBD-1 or
mBD-4, by siRNA [37-38]. Furthermore Wu et al. also found that silencing mBD2, mBD3 or
both defensins resulted in a significant upregulation of TLR2, TLR4 and MyD88 but not
TLR5 or TLR9 [39].
Kumar et  al.  [40]  observed that  pre-treatment  with the TLR5 agonist  flagellin  markedly
reduced the severity of  subsequent P. aeruginosa  infection in C57BL/6 mice.  This  was in
part  due  to  induction  of  corneal  expression  of  the  antimicrobial  molecules,  nitric  oxide
and  CRAMP.  They  also  observed  similar  results  in  vitro,  as  flagellin  pre-treatment  en‐
hanced P. aeruginosa  induced expression of hBD-2 and LL-37 in human corneal epithelial
cells [39]. These observations raise the possibility of utilizing TLR activation as a prophy‐
lactic means of preventing an overwhelming inflammatory response and corneal destruc‐
tion in P. aeruginosa keratitis.
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2.5. Recruited cells
2.5.1. Polymorphonuclear cells
In animal models as characterized by bacterial invasion of the underlying stroma and in‐
tense neutrophil infiltration which results in corneal opacification and potentially loss of vi‐
sion [41-45]. In an murine model of S. aureus keratitis, exposure of corneal epithelium to S.
aureus increased neutrophil recruitment to the corneal stroma, corneal thickness and corneal
haze in normal C57Bl/6 mice, mice deficient TLR4 or TLR9, but not in mice deficient in TLR2
or MyD88, suggesting that S. aureus-induced corneal inflammation is mediated by TLR2 and
MyD88 [46].
In 2005 Huang et al., reported that silencing TLR9 by siRNA in C57BL/6 mice resulted in less
severe inflammation, reduced polymorphonuclear infiltration but consequently increased
bacterial load [47]. These data suggested that TLR9 activation is required to adequately elim‐
inate bacteria but that it also contributes to corneal destruction.
2.5.2. T cell populations
Extensive study of the underlying mechanism of the pathogenesis of P. aeruginosa keratitis
in experimental models has revealed that mice can be divided in two groups based upon
their immune response to the pathogen [48]. BALB/c mice are resistant to P. aeruginosa infec‐
tion as they mount a Th2 based response that facilitates recovery and corneal healing. While
C57BL/6 mice are susceptible to P. aeruginosa infection as they mount a Th1 based immune
response leading to corneal perforation. Comparison among these mouse strains provides a
unique opportunity to understand the immune response to P. aeruginosa.
Exists other type of efectors in the immune response not characterized yet, like the presence
of other receptors like NLR or CLR. It is important to mention that the immune response
previous described are in animal models or in vitro models; a few studies are in patients and
we need to study in the future to explain the immunopathogenesis and found new treat‐
ments for patients.
3. Virulence factors and mechanisms of bacterial resistance
To understand why bacterial keratitis is often of difficult treatment is necessary to first re‐
view the virulence factors and mechanisms of bacterial resistance, this will help us to make
decisions about treatment, patient management and contribute to prevent the emergence
and development resistant strains.
The treatment for bacterial keratitis consist mainly in antibiotics, so it is necessary to know:
bacterial structure, biochemical action, identified important immunogens, and virulence fac‐
tors. Molecular biology also has had a great participation and that made possible the devel‐
opment of molecular techniques with applications to research to learn more about the
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bacterial virulence factors and in the diagnosis of pathogens to give a prompt and timely
treatment [49].
3.1. Virulence factors
Virulence is a term that comes from the Latin virulent (virus = poison and virulent = poison‐
ous) and that is a property to allows pathogenic bacteria to colonize the host and thus obtain
their nutritional requirements, for this it is necessary to evade the defense mechanisms, mul‐
tiply, establish and cause harm. All this is achieved through the expression of bacterial viru‐
lence factors (bacteriocins) that allow microbial adherence, invasion, or both, the
harmfulness and pathogenic microorganism determines its virulence o their ability to do
harm. Within the virulence factors we can mention the following:
• Adhesins. These substances are membrane receptors involved not only in the cell-cell in‐
teractions but also cell-extracellular matrix and cell-trafficking cell. Among the adhesins
find bacterial pili, fimbrial proteins, lipoteichoic acids and glycocalyx.
• Invasins. Surface proteins which are responsible for reorganization of actin filaments near
the cytoskeleton, thus, when a bacterium comes into contact with the host cell occurs a
change in its structure similar to a drop of liquid on a solid surface falls due the reorgani‐
zation of the cytoskeleton so that it can be incorporated into the cell, once inside the bacte‐
ria uses actin to move from one cell to another.
• Impedins. Molecules that help the bacteria evade the host immune response to perpetuate
and maintain their infectivity, as examples we can mention the mucinases that using me‐
chanical effects generated by the movement of flagella prevent skidding and disposal, al‐
so we can mention proteases that are found mainly in the mucous membranes and
destroy the IgA antibodies. In addition exist molecules that help evasion of phagocytosis
as coagulase, DNAse, phosphatases, LPS that interfere with complement and finally the
production of toxic metabolites to overcome the normal flora.
• Aggressins. Hypothetical substance held to contribute to the virulence of pathogenic bac‐
teria by paralyzing the host defensive mechanisms which, by their chemical nature, can
lead to tissue damage, inflammation and shock. Some examples we can cite alpha and be‐
ta toxins, lytic enzymes, DNases, lipases, hyaluronidases, kinases, teichoic acid.
• Modulins are bacterial components that promote the production of cytokines among
which we can find the lipopolysaccharide of Gram(-), superantigens and murein frag‐
ments.
3.2. Bacterial resistance
The principal objective about the study of bacterial virulence factors is the quest from new
preventive and therapeutic tools against many infectious diseases. However, there is anoth‐
er condition called bacterial resistance[50].
Antibiotic resistance in bacteria has become a health problem worldwide. The developments
of new antibacterial drugs, the indiscriminate and irrational use, besides the evolutionary
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pressure exerted by therapeutic use have gone masking the increase of the resistance. It ap‐
pears that the design or discovery of new antibiotics solve the problem, however, also new
mechanisms of resistance are difficult to control
Infections caused by multiresistant bacteria, causing extensive morbidity and mortality and
the cost per hospitalization and complications is high. The selective pressure plays an im‐
portant role in the occurrence of resistant strains and is favored by free prescription and for‐
mal therapeutic use, the widespread use of antimicrobials in immunocompromised patients,
in the intensive care unit, the use of inadequate dose or insufficient duration of antimicrobi‐
al therapy and indiscriminate use without establishing a profile sensitivity of isolates. The
selective pressure is a process of adaptation and this is not an attribute of individual organ‐
isms or nature or life, but it is attributes of a species. In Darwinian terms, the response to the
selective pressure is not the individual, not life or nature as a whole but the population itself
[51], this means that when a treatment is handled improperly, only susceptible organisms
will be destroyed and reduce the bacterial load and hence the infection symptoms, however
resistant microorganisms remain in small amounts and gives rise to a new generation of re‐
sistant strains (figure 1).
Figure 1. Selective pressure after a treatment with dosage, time or inadequate concentration of the antibiotic. (A)
mixture of sensitive and resistant bacteria to an antibiotic (B) Resistant bacteria (C) Proliferation of bacteria resistant
proliferation.
The phenotypic expression of bacterial resistance has intrinsic or acquired genetic basis and
is mainly expressed by biochemical mechanisms [52]. Briefly describe the two mechanisms
of bacterial resistance, the naturally occurring and acquired by the same bacteria.
3.2.1. Natural resistance
Natural resistance is a constant feature of strains of the same bacterial species and is a per‐
manent mechanism determined genetically and furthermore correlated with dose of antibi‐
otic. Some examples of this, we can mention the resistance presented by Proteus mirabilis to
the tetracyclines and colistin, P. aeruginosa to the Benzylpenicillins and trimethoprim-sulfa‐
methoxazole, aerobic Gram(-) bacilli to the clindamycin, Klebsiella pneumoniae to the penicil‐
lins (ampicillin and amoxicillin), [53].
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3.2.2. Acquired resistance
Bacterial species, which by nature is sensitive to an antibiotic, can be genetically modified
either by mutation or by acquisition of resistance genes (plasmids, transposons and inte‐
grons), these are evolutionary and their frequency depends on the use of antibiotics. An ex‐
ample of mutation of a gene involved in the mechanism of action of an antibiotic is the DNA
gyrase involved in DNA replication process of enterobacterias and that a mutation in these
genes can confer resistance to quinolones; can also be mutations generated in genes encod‐
ing the porins which results in blocking the entrance of the antibiotic into the microorgan‐
ism. The acquisition of resistance genes can be obtained by transfer from a strain of a species
identical or different, mechanisms responsible for these are the plasmids, transposons and
integrons [53-54].
The plasmids and transposons are mobile genetic elements which carry resistance genes.
The plasmids are fragments of bacterial DNA with variable length; some have the ability to
replicate independently of the genetic machinery available to the cell. Other hand transpo‐
sons are sequences of DNA (double stranded) which can be translocated from chromosome
to chromosome or a plasmid to plasmids, thanks to a proper recombination system, this
adds to the ability of plasmids to move from one cell to another during conjugation, this al‐
lows the acquisition of resistance genes from bacteria of the same species or different species
which facilitates the expansion of the resistance strains. Some plasmids and transposons
have elements called integrons gene that allows them to capture more exogenous genes de‐
termining the development of resistance to several antibiotics (multiple resistance). Antibi‐
otics particularly affected by this mechanism are the beta-lactams, aminoglycosides,
tetracyclines, chloramphenicol, and sulfonamide, an example is the resistance presented by
Escherichia coli and P. mirabilis to ampicillin [55].
3.3. Resistance mechanisms
Bacterial resistance both acquired and natural can be approached from the standpoint mo‐
lecular and biochemical and can be classified into three basic mechanisms of resistance ex‐
pressed according to the mechanism expressed and the antibiotics mechanism action and
may occur simultaneously [55]. The figure 2 shows a schematic representation of the mecha‐
nisms of resistance.
• Inactivation of antibiotic by destruction or modification of chemical structure. Is a molec‐
ular process characterized by the production of enzymes that carry out this function. For
example, enzymes that destroy the chemical structure of an antibiotic against beta-lacta‐
mases are characterized by hydrolyzing the beta-lactam nucleus through amide bond
cleavage and erythromycin esterase which catalyses the hydrolysis of the lactone ring of
the antibiotic, while the enzymes responsible to the modification of the structure we can
mention the chloramphenicol acetyl transferase, enzymes that modify aminoglycosides,
lincosamides and streptogramins, other enzymes belonging to this group are acetylases,
adenilasas and phosphatases [56, 57].
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• Altered target site of the antibiotic. Is the modification of bacterial specific sites such as
the cell wall, cell membrane, or both 30S and 50S ribosomal subunit. The modification by
mutation of GyrA and GyrB genes that coding for topoisomerase II and IV offer bacterial
resistance to S. aureus, S. epidermidis, P. aeruginosa and E. coli to quinolones [57]. Among
the ribosomal level changes can include changes in the 30S and 50S subunits which are
sites of action of aminoglycosides, macrolides, tetracyclines and lincosamides. Methyla‐
tion of ribosomal RNA from the 50S subunit confers resistance to S. aureus and S. epidermi‐
dis against tetracycline, chloramphenicol and macrolides. Mutation of the 30S subunit
confers resistance to gentamicin, tobramycin and amikacin [55,58].
• Altered permeability barriers. Is due to specific changes in structure of antimicrobial re‐
ceptors or alterations in the components of the wall or cell membrane and occur changes
in the permeability, as well as the loss of the ability of active transport across the cell
membrane or the expression of efflux pumps which are activated at the time that the anti‐
biotic is introduced into the bacterial cell [53]. The internalization of hydrophilic com‐
pounds is carried out by channels called porins which are filled with water, penetration of
the antibacterial in this case depend on the size of the molecule, hydrophobicity and elec‐
tric charge [55].
• Efflux pumps: On the cell membrane are efflux pumps that carry out the internalization
and removal of antimicrobials, a wide variety of these provide antimicrobial resistance
both Gram(+) and Gram(-). Active efflux of antibiotics is mediated by transmembrane
proteins and the Gram(-) bacteria, involves the membrane components and cytoplasm.
These proteins are exported active channels to an antimicrobial agent outside the cell as
fast as it comes. These mechanisms confer resistance to tetracycline, quinolones, chloram‐
phenicol, beta lactam antibiotics, antiseptics and disinfectants quaternary ammonium
type used for cleaning surfaces [53, 55, 57, 58].
3.4. Biofilm production
In nature, bacteria can grow like planktonic or free-floating, but can also grow colonies em‐
bedded in a matrix known as biofilm. Deserves special mention the formation of biofilms,
since being a microbial ecosystem composed of one or more microorganisms associated with
living or inert surface with functional features and complex structures can be considered a
virulence factor and the same time a resistance mechanism. Biofilm formation enables the
adhesion to the surface where the bacteria is present and can be one of many causes of
chronic infections, for example the chronic infectious keratitis. The structural organization of
the bacterial biofilm is composed of polysaccharides, nucleic acids and proteins and all this
set is known as extracellular polymeric substances (EPS) and its production is affected by
the nutritional quality of the environment in which bacteria develop when the environment
is suitable to form biofilms with multiple microcolonies, so the structure that forms is so
great that prevents phagocytosis and effects of the immune system against them, for this
reason is considered a virulence factor. A very important advantage from the clinical point
of view is that biofilms confer resistance to antibiotics such that the dose can be increased
thousands of times without causing damage [59]. Two hypotheses to explain the resistance
Bacterial Keratitis Infection: A Battle Between Virulence Factors and the Immune Response
http://dx.doi.org/10.5772/52264
93
generated by the production of biofilms, the first indicating that occurs a limited penetration
of the drug and the bulk is left on the surface such that the antibiotic never reaches its target.
The second refers to the physiological limitation and proposes that some microorganisms
within the biofilm can exist in a more recalcitrant phenotypic state. Anderl JN et al [60] in a
study of K. pneumoniae found that the planktonic form was sensitive to ampicillin and re‐
ported minimum inhibitory concentration (MIC) of 22µg/mL while the same strain that
grew as a biofilm presented a survival of 66% increasing the concentration of ampicillin to
5000µg/mL which corresponds to 2500 times the MIC.
Figure 2. Resistant mechanism (1) Altered target site of the antibiotic and altered permeability barriers (2) Inactivation
of antibiotic by destruction or modification of chemical structure (3) Efflux pumps (4) acquisition of resistance genes
by fagos (5) Plasmids (6) Transposons and Integrons (7) modification by mutation of topoisomerase.
Having recognized the role of biofilm as responsible of infectious diseases, it is necessary the
search for new approaches in both the treatment and prevention. A proposal to counteract
this resistance factor is the alteration of the surface to inhibit adhesion. In the area of oph‐
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thalmology, for example, chelating agents could be used in contact lens solutions, mainly
iron-trapping agent which is necessary for adhesion of the pili of Pseudomonas sp. [59, 60].
Figure 3. Biofilm production (1) Planktonic bacteria encounter a submerged surface. They begin to produce slimy ex‐
tracellular polymeric substances (EPS) and to colonize the surface. (2) EPS production allows the emerging biofilm
community to develop a complex three-dimensional structure (3) Biofilms can propagate through detachment of
small or large clumps of cells that releases individual cells.
4. Clinical characteristics
4.1. Common characteristics
When developing a bacterial corneal ulcer usually appears chemosis and conjunctival injec‐
tion, eyelid edema, decreased vision, pain, tearing, photophobia, and purulent discharge.
Conjunctival reaction is nonspecific, with a predominantly papillary response, is primarily
limbal injection. The corneal epithelium and stroma ulcer shows a gray-white infiltrate, may
appear necrotic. Infiltration and edema of the cornea can be observed even in areas remote
from the ulcer. Appears frequently, an anterior chamber reaction, and in severe cases can be
observed fibrin plates on the endothelium and may be a fibrinoid aqueous or hypopyon
[61-64].
The hypopyon is produced by the toxic effects of infection on vessels iris and ciliary body,
with consequent pouring of fibrin and polymorphonuclear leukocytes. Usually, the hypopy‐
on is sterile as Descemet's membrane is intact. Hypopyon can be seen with any bacterial in‐
fection, most frequently in ulcers caused by S. pneumoniae and Pseudomonas sp.; not
forgetting also can occur in viral and fungal ulcers [64-66].
Signs and symptoms of bacterial corneal ulcers vary depending on the virulence of the or‐
ganism, the previous state of the cornea, the duration of infection, host immune status and
prior use of antibiotics and steroids [67-70]. The use of hydrophilic contact lenses can alter
the presentation of bacterial ulcers. Infections associated with contact lenses are often multi‐
focal and epithelial and stromal infiltrate is more diffuse. The contact lens wearers present‐
ing with corneal abrasions may have bacterial infections early[71, 72]. Figure 4 are clinical
pictures representative in bacterial keratitis.
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The aspect sometimes ulcer suggesting the presence of a specific bacterial agent or a group
of them. Are indicated below the characteristic signs of infection caused by some agents.
However, one must take into account the clinical aspect is never diagnosis, isolation and
identification of causative agents is always essential.
4.2. Staphylococcus sp.
S. aureus produces coagulase and mannitol fermentation being more aggressive, and S. epider‐
midis does not produce coagulase or ferment mannitol. The latter two are usually opportunis‐
tic pathogens that cause infections in compromised corneas, for example, persistent epithelial
defects, bullous keratopathy, herpetic epitheliopathy, diabetic epitheliopathy, etcetera. The
corneal appearance in S. aureus, has a round or oval ulcer, localized, with distinct edges and
tends to be deeper, usually accompanied by a creamy white stromal infiltrate and well-de‐
fined gray with overlying epithelial defect and can be multifocal. In severe cases, you can get
to see hypopyon and endothelial plaque, staphylococcal blepharitis is common [73-75].
Figure 4. Representative Clinical pictures of patients with Bacterial Keratitis infection..
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4.3. Pseudomonas sp.
Pseudomonas sp. is a Gram(-) often associated with contact lens use, which adheres to the
damaged epithelium and stromal cause rapid invasion, the ulcer has a deep peripheral ex‐
tension in  hours  (can reach twice  its  size  in  24  hrs.)  peripheral  infiltration with  diffuse
gray,  yellow-green  discharge,  severe  reaction  and  hypopyon  in  the  anterior  chamber,
which may extend to sclera and cause necrotizing scleritis and/or perforation in 2-5 days.
You can also get to see a multifocal pattern that is more associated with use of soft contact
lens [67, 76].
4.4. Streptococcus sp.
S. pneumoniae isolates in the upper respiratory tract half of the population, their proximity to
the eye may explain the frequency of problems associated with it. Streptococcus sp. generates
hemolysis of erythrocytes, being in full by the S. pyogenes, and partially by the alpha hemo‐
lytic as S. viridans and S. pneumoniae. The infection usually arises after corneal trauma and is
often associated with chronic dacryocystitis. We present a deep stromal abscess with fibrin
deposition, plaque formation, severe anterior chamber reaction, hypopyon, synechiae iridi‐
anas, if left untreated can lead to perforation. S. viridans has a less aggressive course and is
responsible for cristalinean keratopathy, also related to the indiscriminate use of topical an‐
esthetic, use of contact lenses and chemical burns [77-79].
4.5. Bacillus sp.
Bacillus cereus are bacilli anaerobic Gram + in soil, water and vegetation. The infection usual‐
ly occurs within 24 hours after penetrating trauma in the presence of chemosis, severe eyelid
edema, proptosis, edema peripheral microcystic with a ring followed by a circumferential
corneal abscess may lead to drilling in hours [80-82].
4.6. Less common infectious agents
4.6.1. Corynebacterium diphtheriae
Corynebacterium diphtheriae are bacilli Gram + that rarely causes corneal disease but does re‐
mark commonly as a cause of pseudomembranous conjunctivitis with preauricular lympha‐
denopathy resulting in corneal epithelial opacity diffuse stromal necrosis and thinning
[83-87].
4.6.2. Listeria monocytogenes
Listeria monocytogenes is a facultative anaerobe that causes infection in people who are dedi‐
cated to animal care. It is colonizing persistent epithelial defects and keratitis developed a
type of necrotizing ulcer-shaped ring with large anterior chamber reaction, fibrinoid exuda‐
tion and hypopyon [87-89].
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4.6.3. Propionibacterium acnes
Propionibacterium acnes are bacilli anaerobic Gram + rod that is part of normal flora, so the
infection occurs before a surgical trauma, contact lens use, chronic use of steroids or other
associated corneal disease. It takes the form of corneal stromal abscess with intact epitheli‐
um [90-93].
5. Conclusions
In order to minimize the effect of bacterial resistance have begun to develop programs
among which we mention the use of antibiotics, increased medical education plans in the
study of infectious diseases, the use of antimicrobial agents and their prescription based on
the evidence, the establishment of surveillance programs to detect the emergence of resistant
strains, and improving the quality of antimicrobial susceptibility methods.
In the future it will continue to develop new antibiotic molecules looking to have a bet‐
ter effect.  However, we must control a number of factors that facilitate the increase and
acceleration of development of resistance, it is necessary to continuously monitor the lev‐
els of resistance of each bacterial species and thus able to make a rational antibiotic selec‐
tion  for  the  benefit  of  patients  and  reduce  the  risk  of  developing  resistance.  Simple
measures and common sense will remain the main limiting resource for development of
bacterial resistance.
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